SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Mirati Therapeutics Q1 EPS $(2.020) Down From $(1.170) YoY, Sales $267.000K Down From $1.244M YoY

Mirati Therapeutics (NASDAQ:MRTX) reported quarterly losses of $(2.020) per share. This is a 72.65 percent decrease over losses of $(1.170) per share from the same period last year. The company reported $267.000

Benzinga · 05/07/2020 20:40

Mirati Therapeutics (NASDAQ:MRTX) reported quarterly losses of $(2.020) per share. This is a 72.65 percent decrease over losses of $(1.170) per share from the same period last year. The company reported $267.000 thousand in sales this quarter. This is a 78.54 percent decrease over sales of $1.244 million the same period last year.